A survey conducted in April and May 2023 revealed that around ** percent of the companies that do business in the European Union (EU) and the United Kingdom (UK) found it challenging to adapt to new or changing requirements of the General Data Protection Regulation (GDPR) or Data Protection Act 2018 (DPA). A further ** percent of the survey respondents said it was challenging to increase the budget because of the changes in the data privacy laws.

As of February 2025, the largest fine issued for violation of the General Data Protection Regulation (GDPR) in the United Kingdom (UK) was more than 22 million euros, received by British Airways in October 2020. Another fine received by Marriott International Inc. in the same month was the second-highest in the UK and amounted to over 20 million euros.

A survey conducted in April and May 2023 among companies that do business in the European Union and the United Kingdom (UK) found that over half of the respondents, ** percent, felt very prepared for the General Data Protection Regulation (GDPR). A further ** percent of the companies believed they were moderately prepared, while ** percent said they were slightly ready to comply with the EU and UK privacy legislations.

This dataset is a central catalogue of Data Protection Impact Assessments (DPIAs) of smart city projects that collect personal information in public spaces. By publishing this in one place for the first time, it will enable public transparency and support good practice among operators. A DPIA helps to identify and minimise the risks of a project that uses personal data. Further information: DPIA registration form: https://www.london.gov.uk/dpia-register-form Information Commissioner DPIA: https://ico.org.uk/for-organisations/guide-to-data-protection/guide-to-the-general-data-protection-regulation-gdpr/accountability-and-governance/data-protection-impact-assessments/

Since the enforcement of the General Data Protection Regulation (GDPR) in May 2018, fines have been issued for several types of violations. As of February 2025, the most significant share of penalties was due to companies' non-compliance with general data processing principles. This violation has led to over 2.4 billion euros worth of fines.

Between 2018 and 2022, there has been a significant increase in the level of awareness around the General Data Protection Regulation (GDPR) among European users. In 2018, when the GDPR was first applied, the United Kingdom had the highest level of awareness, with 32 percent of respondents agreeing or strongly agreeing with the statement: "I am aware of the new General Data Protection Regulation (GDPR) that will be introduced in May 2018". In 2022, the share of UK respondents agreeing with the statement increased to 73 percent. France had the lowest level of awareness in 2018, 20 percent, whereas in 2022 it reached 47 percent but remained the lowest among other European markets.

IntroductionThe ubiquity of Bring Your Own Device (BYOD) personal smartphones, Instant Messaging (IM), and third-party apps, has made these technologies compelling for efficient communications between clinicians regarding patient care. However, the sensitivity of patient-related information necessitates secure, GDPR compliant modalities that prevent unauthorised access and ensure confidentiality. This scoping review explores existing guidelines, policies, and regulations that advise clinicians in the UK and Ireland on the secure use of these digital communication tools.MethodsFollowing the Joanna Briggs Institute (JBI) updated Framework for Scoping Reviews and the PRISMA ScR guidelines, this review examines the literature to identify relevant guidelines, policies, and regulations informing current clinical practice on the use of this technology. Academic databases including OneSearch, Embase, EBSCO, PubMed, Medline, and CINAHL were searched, in addition to hand searches of professional entities' websites, including trade unions, regulators, two national health systems, and several employers. Direct inquiries were made to 69 professional entities via telephone, email, websites, and X (formerly known as Twitter).ResultsThe review identified 18 papers that broadly recognise the importance of secure communication however, a lack of information on the appropriate selection or configuration of these popular technologies was evident. Most guidelines emphasise general security and data protection standards rather than providing clear actionable recommendations for technology use, thereby leaving a significant gap in technical guidance for clinicians.DiscussionThere is a distinct lack of detailed, specific, consistent technical guidance available to clinicians. This review evidences an urgent requirement for enhanced guidelines that specify the most secure platforms, appropriate features, and configuration to maximise the security and confidentiality of clinical communications. Further research is recommended to develop comprehensive, actionable advice for clinicians.

A Data Protection Impact Assessment (DPIA) is one of the ways to find out what privacy risks people face when information is collected, used, stored, or shared about them. This helps the London Borough of Barnet find issues so that risks can be taken away or lowered to a level that is acceptable. It also cuts down on privacy breaches and complaints that could hurt the Council's reputation or lead to action by the Information Commissioner (the government watchdog). The London Borough of Barnet makes DPIAs public in with its Data Charter and the 2018 Data Protection Act and UK GDPR.

Whilst this some of the requested information is held by the NHSBSA, we have exempted some of the figures under section 40(2) subsections 2 and 3(a) of the FOIA because it is personal data of applicants to the VDPS. This is because it would breach the first data protection principle as: a - it is not fair to disclose individual’s personal details to the world and is likely to cause damage or distress. b - these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the individual. https://www.legislation.gov.uk/ukpga/2000/36/section/40 Information Commissioner Office (ICO) Guidance is that information is personal data if it ‘relates to’ an ‘identifiable individual’ regulated by the UK General Data Protection Regulation (UK GDPR) or the Data Protection Act 2018. The information relates to personal data of the VDPS claimants and is special category data in the form of health information. As a result, the claimants could be identified, when combined with other information that may be in the public domain or reasonably available. Online communities exist for those adversely affected by vaccines they have received. This further increases the likelihood that those may be identified by disclosure of this information. Section 40(2) is an absolute, prejudice-based exemption and therefore is exempt if disclosure would contravene any of the data protection principles. To comply with the lawfulness, fairness, and transparency data protection principle, we either need the consent of the data subject(s) or there must be a legitimate interest in disclosure. In addition, the disclosure must be necessary to meet the legitimate interest and finally, the disclosure must not cause unwarranted harm. The NHSBSA has considered this and does not have the consent of the data subjects to release this information and believes that it would not be possible to obtain consent that meets the threshold in Article 7 of the UK GDPR. The NHSBSA acknowledges that you have a legitimate interest in disclosure of the information to provide the full picture of data held by the NHSBSA; however, we have concluded that disclosure of the requested information would cause unwarranted harm and therefore, section 40(2) is engaged. This is because there is a reasonable expectation that patient data processed by the NHSBSA remains confidential, especially special category data. There are no reasonable alternative measures that could meet the legitimate aim. As the information is highly confidential and sensitive, it outweighs the legitimate interest in the information. Section 41 FOIA This information is also exempt under section 41 of the FOIA (information provided in confidence). This is because the requested information was provided to the NHSBSA in confidence by a third party - another individual, company, public authority or any other type of legal entity. In this instance, details have been provided by the claimants. For Section 41 to be engaged, the following criteria must be fulfilled:

Este conjunto de dados é um catálogo central de avaliações de impacto sobre a proteção de dados (AIPD) de projetos de cidades inteligentes que recolhem informações pessoais em espaços públicos. Ao publicá-lo num único local pela primeira vez, permitirá a transparência pública e apoiará as boas práticas entre os operadores.

Uma AIPD ajuda a identificar e minimizar os riscos de um projeto que utiliza dados pessoais.

Formulário de inscrição na DPIA: "https://www.london.gov.uk/dpia-register-form" target="_blank" style="color: rgb(158, 0, 98);">https://www.london.gov.uk/dpia-register-form

Information Commissioner DPIA: "https://data.london.gov.uk/dpia/_wp_link_placeholder" target="_blank" style="color: rgb(158, 0, 98);">https://ico.org.uk/for-organisations/guide-to-data-protection/guide-to-the-general-data-protection-regulation-gdpr/accountability-and-governance/data-protection-impact-assessments/

In the United Kingdom, consumer concerns around use of personal data by companies centered on more accountability from the side of the companies, according to a survey conducted among internet users in the UK. ** percent of respondents said they thought companies should be held accountable in the case of data misuse. Another ** percent of consumers who took part in the survey said they wanted to see transparency on marketing and advertising practices carried out by companies.

Uncover a wealth of market insights with our comprehensive Ecommerce dataset, meticulously collected using advanced web automation techniques. Our web-scraped dataset offers a diverse range of product information from various Ecommerce platforms, enabling you to gain a competitive edge and make informed business decisions.

Key Features:

Extensive Ecommerce Coverage: Our dataset spans across multiple Ecommerce platforms, providing a comprehensive view of product listings, pricing, descriptions, customer reviews, and more. Analyze trends, monitor competitor performance, and identify market opportunities with ease.

Real-Time and Dynamic Data: Leveraging cutting-edge web automation technology, our dataset is continuously updated to provide you with real-time and accurate Ecommerce data. Stay ahead of the competition by accessing the latest product information, pricing fluctuations, and customer feedback.

GDPR Compliance: We prioritize data privacy and strictly adhere to the General Data Protection Regulation (GDPR) guidelines. Our dataset collection process ensures that personal and sensitive information is handled securely and with utmost confidentiality.

Rich Attribute Set: Our dataset includes a wide range of attributes, such as product details, images, specifications, seller information, customer ratings, and reviews. Leverage this comprehensive information to conduct in-depth market analysis, product benchmarking, and customer sentiment analysis.

Customizable Data Delivery: We offer flexible data delivery options to suit your specific needs. Choose from formats such as CSV, JSON, or API integration for seamless integration with your existing data infrastructure.

BackgroundThe COVID-19 pandemic brought global disruption to health, society and economy, including to the conduct of clinical research. In the European Union (EU), the legal and ethical framework for research is complex and divergent. Many challenges exist in relation to the interplay of the various applicable rules, particularly with respect to compliance with the General Data Protection Regulation (GDPR). This study aimed to gain insights into the experience of key clinical research stakeholders [investigators, ethics committees (ECs), and data protection officers (DPOs)/legal experts working with clinical research sponsors] across the EU and the UK on the main challenges related to data protection in clinical research before and during the pandemic.Materials and methodsThe study consisted of an online survey and follow-up semi-structured interviews. Data collection occurred between April and December 2021. Survey data was analyzed descriptively, and the interviews underwent a framework analysis.Results and conclusionIn total, 191 respondents filled in the survey, of whom fourteen participated in the follow-up interviews. Out of the targeted 28 countries (EU and UK), 25 were represented in the survey. The majority of stakeholders were based in Western Europe. This study empirically elucidated numerous key legal and ethical issues related to GDPR compliance in the context of (cross-border) clinical research. It showed that the lack of legal harmonization remains the biggest challenge in the field, and that it is present not only at the level of the interplay of key EU legislative acts and national implementation of the GDPR, but also when it comes to interpretation at local, regional and institutional levels. Moreover, the role of ECs in data protection was further explored and possible ways forward for its normative delineation were discussed. According to the participants, the pandemic did not bring additional legal challenges. Although practical challenges (for instance, mainly related to the provision of information to patients) were high due to the globally enacted crisis measures, the key problematic issues on (cross-border) health research, interpretations of the legal texts and compliance strategies remained largely the same.

I can confirm that we do hold information on the names and General Medical Council (GMC) numbers for independent medical assessors. Please note that this response does not relate to a specific claim or claimant. The request is being answered more generally given requests under FOIA are requester-blind, that is to say the identity of the requester is not taken into account when considering a request for information under FOIA. We consider the name and GMC number to be personal data under the Data Protection Act 2018. Disclosure of their names or GMC numbers would result in their identification when entered into the GMC public register. Please be aware that I have decided not to release the names and GMC numbers of the independent medical assessors as this information falls under the exemption in section 40 subsections 2 and 3(A)(a) of the FOIA. As the requested information would allow an independent medical assessor to be identified, I consider this information is exempt. This is because it would breach the first data protection principle as: A. it is not fair to disclose their personal details to the world and is likely to cause damage or distress. B. these details are not of sufficient interest to the public to warrant an intrusion into their privacy. The requested information is exempt if disclosure would contravene any of the data protection principles. For disclosure to comply with the lawfulness, fairness, and transparency principle, we either need the consent of the data subject(s) or there must be a legitimate interest in disclosure. In addition, the disclosure must be necessary to meet the legitimate interest and finally, the disclosure must not cause unwarranted harm. This means that the NHSBSA is therefore required to conduct a balancing exercise between the legitimate interest of the applicant in disclosure against the rights and freedoms of the independent medical assessor. While I acknowledge that you have a legitimate interest in disclosure of the information, the disclosure of the requested information would cause unwarranted harm. Disclosure under FOIA is to the world and therefore the NHSBSA has to consider the overall impact of the disclosure and its duty of care. The expectation of the independent medical assessors is that they will remain anonymous and will therefore not be subject to contact or pressure from claimants or campaigning groups. Given the certainty that the name and/or GMC number will identify them, there is a reasonable expectation that this information will not be disclosed under the FOIA. Disclosing this information would be unfair and as such this would breach the UK General Data Protection Regulation first data protection principle. Please see the following link to view the section 40 exemption in full: https://www.legislation.gov.uk/ukpga/2000/36/section/40 Qualifications and experience The NHSBSA does not hold information on the independent medical assessors' qualifications. This is because their medical qualifications and experience are the responsibility of the third-party medical assessment supplier. I hope, however, that the following information provides reassurance on this point: All claims are assessed by the independent medical assessment company with a consistent approach. Each case is considered on its own merits, by an experienced independent medical assessor. The contract with our supplier does not require them to tell us details of their qualifications or their experience.

In September 2024, the Irish Data Protection Commission fined Meta Ireland 91 million euros after passwords of social media users were stored in 'plaintext' on Meta's internal systems rather than with cryptographic protection or encryption. In May 2023, the EU fined Meta 1.2 billion euros for violating laws on digital privacy and putting the data of EU citizens at risk through Facebook's EU-U.S. data transfers. European privacy legislation is seen as being far stricter than American privacy law, and the sending of EU citizens’ data to the United States resulted in the record breaking penalty being issued to the tech giant. In January 2023, after it was discovered that Meta Platforms had improperly required that users of Facebook, Instagram, and WhatsApp accept personalized adverts to use the platforms, the company was issued a 390 million euro fine by the European Commission. EU regulators claim that the social media giant broke the General Data Protection Regulation (GDPR) by including the demand in its terms of service. In addition, Meta was fined 405 million euros by the Irish Data Protection Commission (DPC) in September 2022 for violating Instagram's children's privacy settings. In November 2022, the DPC fined Meta a further 265 million euros for failing to protect their users from data scraping. GDPR violations in 2022 Social media sites and companies are not the only types of online services upon which users' data can potentially be compromised. In 2022, the online service with the biggest fine for violating GDPR was e-commerce and digital powerhouse Amazon, which was issued a 746 million euro fine. Furthermore, in December 2021, Google was penalized 90 million euros for GDPR violations. What are the most common GDPR violations? Since GDPR went into effect in May 2018, fines have been imposed for a variety of reasons. As of June 2022, companies' non-compliance with general data processing principles accounted for the largest share of fines, resulting in over 845 million euros worth of penalties. Insufficient legal basis for data processing was the second most common violation, amounting to 447 million euros in fines.

Unlock the Power of Behavioural Data with GDPR-Compliant Clickstream Insights.

Swash clickstream data offers a comprehensive and GDPR-compliant dataset sourced from users worldwide, encompassing both desktop and mobile browsing behaviour. Here's an in-depth look at what sets us apart and how our data can benefit your organisation.

User-Centric Approach: Unlike traditional data collection methods, we take a user-centric approach by rewarding users for the data they willingly provide. This unique methodology ensures transparent data collection practices, encourages user participation, and establishes trust between data providers and consumers.

Wide Coverage and Varied Categories: Our clickstream data covers diverse categories, including search, shopping, and URL visits. Whether you are interested in understanding user preferences in e-commerce, analysing search behaviour across different industries, or tracking website visits, our data provides a rich and multi-dimensional view of user activities.

GDPR Compliance and Privacy: We prioritise data privacy and strictly adhere to GDPR guidelines. Our data collection methods are fully compliant, ensuring the protection of user identities and personal information. You can confidently leverage our clickstream data without compromising privacy or facing regulatory challenges.

Market Intelligence and Consumer Behaviour: Gain deep insights into market intelligence and consumer behaviour using our clickstream data. Understand trends, preferences, and user behaviour patterns by analysing the comprehensive user-level, time-stamped raw or processed data feed. Uncover valuable information about user journeys, search funnels, and paths to purchase to enhance your marketing strategies and drive business growth.

High-Frequency Updates and Consistency: We provide high-frequency updates and consistent user participation, offering both historical data and ongoing daily delivery. This ensures you have access to up-to-date insights and a continuous data feed for comprehensive analysis. Our reliable and consistent data empowers you to make accurate and timely decisions.

Custom Reporting and Analysis: We understand that every organisation has unique requirements. That's why we offer customisable reporting options, allowing you to tailor the analysis and reporting of clickstream data to your specific needs. Whether you need detailed metrics, visualisations, or in-depth analytics, we provide the flexibility to meet your reporting requirements.

Data Quality and Credibility: We take data quality seriously. Our data sourcing practices are designed to ensure responsible and reliable data collection. We implement rigorous data cleaning, validation, and verification processes, guaranteeing the accuracy and reliability of our clickstream data. You can confidently rely on our data to drive your decision-making processes.

Forecast: General Government Expenditure on Social Protection in the UK 2023 - 2027 Discover more data with ReportLinker!